Find Etanercept manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

8RELATED EXCIPIENT COMPANIES

13EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

FDA Orange Book

read-more
read-more

01

IMMUNEX

U.S.A
Aus. Peptide Conference
Not Confirmed
arrow

IMMUNEX

U.S.A
arrow
Aus. Peptide Conference
Not Confirmed

ETANERCEPT

Brand Name : ENBREL

Dosage Form : VIAL; SUBCUTANEOUS

Dosage Strength : 25MG/VIAL

Approval Date :

Application Number : 103795

RX/OTC/DISCN :

RLD :

TE Code :

blank

02

IMMUNEX

U.S.A
Aus. Peptide Conference
Not Confirmed
arrow

IMMUNEX

U.S.A
arrow
Aus. Peptide Conference
Not Confirmed

ETANERCEPT

Brand Name : ENBREL

Dosage Form : SYRINGE

Dosage Strength : 50MG/ML

Approval Date :

Application Number : 103795

RX/OTC/DISCN :

RLD :

TE Code :

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ETANERCEPT-YKRO

Brand Name : ETICOVO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25MG/0.5ML

Approval Date :

Application Number : 761066

RX/OTC/DISCN :

RLD :

TE Code :

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ETANERCEPT-YKRO

Brand Name : ETICOVO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 50MG/1ML

Approval Date :

Application Number : 761066

RX/OTC/DISCN :

RLD :

TE Code :

blank

05

SANDOZ

Switzerland
Aus. Peptide Conference
Not Confirmed
arrow

SANDOZ

Switzerland
arrow
Aus. Peptide Conference
Not Confirmed

ETANERCEPT-SZZS

Brand Name : ERELZI

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 25MG/0.5ML

Approval Date :

Application Number : 761042

RX/OTC/DISCN :

RLD :

TE Code :

blank

06

SANDOZ

Switzerland
Aus. Peptide Conference
Not Confirmed
arrow

SANDOZ

Switzerland
arrow
Aus. Peptide Conference
Not Confirmed

ETANERCEPT-SZZS

Brand Name : ERELZI

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 50MG/ML

Approval Date :

Application Number : 761042

RX/OTC/DISCN :

RLD :

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

read-more
read-more

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Brenzys

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Brenzys

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Brenzys

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Brenzys

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Nepexto

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Enbrel

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Enbrel

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Enbrel

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Enbrel

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : Enbrel

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Taste Masking

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

Health Canada Patents

read-more
read-more

01

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : ENBREL

Patent Number : 2366785

Filing Date : 2000-04-19

Strength per Unit : 25 mg / vial

Dosage Form : Lyophilized Powder for Reconstitution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2020-04-19

Date Granted : 2012-02-07

blank

02

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : ENBREL

Patent Number : 2366785

Filing Date : 2000-04-19

Strength per Unit : 50 mg / ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2020-04-19

Date Granted : 2012-02-07

blank

03

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : ENBREL

Patent Number : 2123593

Filing Date : 1993-09-14

Strength per Unit : 25 mg / vial

Dosage Form : Lyophilized Powder for Reconstitution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2013-09-14

Date Granted : 2000-03-14

blank

04

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : ENBREL

Patent Number : 2045869

Filing Date : 1991-06-27

Strength per Unit : 25 mg / vial

Dosage Form : Lyophilized Powder for Reconstitution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2011-06-27

Date Granted : 2009-01-27

blank

05

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : ENBREL

Patent Number : 2476934

Filing Date : 2003-02-27

Strength per Unit : 50 mg / ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2023-02-27

Date Granted : 2009-06-16

blank

06

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

Etanercept

Brand Name : ENBREL

Patent Number : 2045869

Filing Date : 1991-06-27

Strength per Unit : 50 mg / ml

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2011-06-27

Date Granted : 2009-01-27

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty